Newsletter
Every new paper in this field, in your inbox.
Researchers analyzed data from 2020 to 2040 to understand the trends in pancreatic cancer (PC) incidence and mortality worldwide. PC is linked to higher socioeconomic status, with Asia, especially China, bearing the greatest burden. Among age groups, those aged 65 and older are most affected,…
Researchers investigated the volumetric changes in the left liver after right hepatectomy and the factors influencing the degree of hypertrophy and severe post-hepatectomy liver failure (PHLF). After right hepatectomy, the left liver remnant exhibited a 25% hypertrophy with varying growth rates. Factors like gender, middle…
This study delves into the use of allogeneic vessels (AV) in pancreaticoduodenectomy (PD) with portal vein resection (PVR) and its relationship with portal vein thrombosis (PVT). The findings reveal that PVT is notably prevalent, especially in cases involving AV reconstructions. Independent risk factors for PVT…
This study delves into pancreatic cancer outcomes in the disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) population, which is often underrepresented in scientific research. Analyzing data from 296,448 patients, it reveals that AANHPI patients, as a whole, exhibited better median survival than Caucasians…
This groundbreaking study analyzed the outcomes of robotic hepatectomy for five major malignant liver diseases. Among the 210 patients who underwent this procedure, including cases like colorectal liver metastases and hepatocellular carcinoma, the results were promising. A favorable 5-year overall survival benefit was observed across…
In a randomized clinical trial, researchers compared laparoscopic and open pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma. The study found that, despite longer operative times, laparoscopic procedures led to less blood loss. Both groups had similar 90-day mortality, rates of complications, and postoperative length of…
Researchers examined the post-recurrence progression in patients with resected pancreatic ductal adenocarcinoma (PDAC) and the implications for treatment. Most PDAC patients experience recurrence within two years, with varying survival outcomes depending on the site of recurrence. Lung recurrence showed significantly longer post-recurrence survival. A subset…
An international multicenter study analyzed 459 patients who underwent pancreatic resection for adenocarcinoma originating from intraductal papillary mucinous neoplasia (IPMN). Results showed that recurrence was common, with 45.5% experiencing it, including 23.2% with early recurrence within a year. Treatment of recurrence, such as adjuvant chemotherapy…
Researchers in southwestern China developed a predictive tool called a nomogram to help identify patients with hepatocellular carcinoma (HCC) who are at risk of experiencing moderate-to-severe complications after hepatectomy surgery. The nomogram uses six variables, including diabetes and the extent of liver resection, to estimate…
Researchers conducted a retrospective study with 88 patients who underwent liver resection for hepatic alveolar echinococcosis. They found that monitoring anti-recEm18 antibody levels was a valuable tool for post-surgical surveillance. Specifically, patients with elevated preoperative anti-recEm18 values can rely on this marker to confirm the…
